Emerging research suggest Retatrutide , a dual agonist targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may provide a promising step forward for obesity management . Early human https://bookmarkspring.com/story16594058/the-retatrutide-peptide-substance-a-advancement-in-weight-management